PATENT CLAIM ANALYSIS

Application Number: 15957457
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "131100"]

Abstract:
The aspects disclosed herein describe methods of identifying a subject that is non-responsive to anti-TNF therapy. The aspects disclosed herein further provide for a method of selecting a therapy for a subject with Inflammatory Bowel Disease (IBD), and treating the subject with the therapy.

Claim (Index 18):
The method of  claim 12 , wherein the genetic risk variant is detected by contacting the sample obtained from the subject with a nucleic acid sequence capable of hybridizing to 10 contiguous nucleobases of rs5745994 (SEQ ID NO. 1) spanning nucleobase 256 under standard hybridization conditions, wherein the standard hybridization conditions comprise an annealing temperature between about 30\u00b0 C. and about 65\u00b0 C.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.48485
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13840779', '12851517', '15030790', '13322863', '15571734']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6869085268035244
- 35 USC 102 Novelty (BERT): 0.4946089164583312
- Combined Prediction Score: 0.6676785657690051
- Mean Citation Score: 146.174042
- Max Citation Score: 165.7468
- Similarity Product: 104.8355216054678

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test